Research Analyst, Global Healthcare- Non- Therapeutics

Founded in 1997, Marshall Wace is a leading global alternatives investment manager specializing in long/short equity. We combine fundamental investing with systematic and quantitative strategies to deliver returns from a range of investment solutions. We are one of the world’s largest alternative asset managers, managing $70 billion with over 700 employees working across London, New York, Hong Kong, Shanghai and Singapore.

Our history is one of continuous development and innovation, from being the creators of the TOPS Alpha Capture System, to the extensive use of proprietary systems throughout our investment and operations environment. In a challenging industry we seek to be competitive by bringing together people from diverse backgrounds and providing them with the systems, data, technology, and work environment they need to succeed. Our culture enables innovative ideas to surface from all areas of the firm and to be executed quickly. TOPS is an exceptional example of how innovation within Marshall Wace has created a unique investment solution for clients and driven many areas of the firm to improve efficiency and key processes and controls.

In September 2015, KKR and Marshall Wace announced the formation of a long-term strategic partnership, with KKR initially acquiring 25pct in Marshall Wace. KKR has market leadership positions in Private Equity and Credit markets, which complement Marshall Wace’s market leadership position in Equity Long/Short, liquid alternative products. The strategic partnership is based on a shared vision of how financial markets are changing and how best to serve clients’ evolving investment requirements, bringing together strong traditions of investment expertise, innovation, entrepreneurship, and cultural alignment. In time, it will enable the joint development of new products, the potential for an expanded global client base, and allow the creation of incentive plans for the next generation of Marshall Wace partners and staff.

Role Details

Marshall Wace’s fundamental strategies are designed to capture stock based idiosyncratic alpha and are 
concentrated in specific regions and sectors. We seek to achieve exceptional returns at all stages of the investment 
process through creative idea generation, rigorous due diligence, company meetings, detailed financial modeling, 
disciplined portfolio construction and efficient trading and implementation. 

Responsibilities

•  Generate long and short equity investment recommendations supported by detailed financial modeling 
  and proprietary research
• Active and ongoing monitoring of portfolio holdings
• Participate in quarterly earnings calls and monitor news events related to companies under coverage, 
  updating the models accordingly
• Attend industry conferences and management meetings, build relationships with sell-side analysts and 
  research associates
• Conduct extensive and differentiated bottoms-up financial analysis of companies, business models, 
  relevant industry metrics and industries
• Evaluate new coverage opportunities
• Identify and analyze relevant industry metrics 

 

Requirements:

• Relevant experience in the healthcare sector is preferred but not required.
• 3-7 years of relevant experience across private equity, long-only and/or long/short equity
• Bachelor’s degree and MBA or equivalent experience with excellent academic credentials
• Strong written and verbal communication skills
• Demonstrated interest in and enthusiasm for the public market investing and fundamental analysis
• Advanced understanding of accounting/financial statements with the ability to identify key drivers of a 
  business and industry
• Excellent Excel modeling skills
•  A self-starter mentality with an ability to learn quickly in a fast-paced environment
• Collaborative, team-oriented personality 

Base salary: $150,000- 175,000. Please note base salary ranges are an estimate; compensation will be candidate dependent. Employees are also eligible for a discretionary bonus.